|
8:00 am - 8:05 am
|
|
OPENING SESSION
|
|
Welcome and opening remarks
|
|
S Lamberts (Rotterdam, The Netherlands)
|
| |
|
8:05 am - 9:45 am
|
|
SESSION ONE
|
|
Chairs: D Clemmons (Chapel Hill, NC, USA),
|
|
R Clayton (Stoke-on-Trent, UK)
|
| |
|
Pathogenesis
|
|
Molecular pathogenesis
|
|
S Melmed (Los Angeles, CA, USA)
|
|
Feed-back tumors
|
|
SL Asa (Toronto, Canada)
|
|
Genetic syndromes
|
|
CA Stratakis (Rockville, MD, USA)
|
|
Management of non-pituitary tumors (craniopharyngeomas)
|
|
ER Laws (Charlottesville, VA, USA)
|
|
|
| |
|
9:45 am - 10:45 am
|
|
Poster viewing and coffee break
|
| |
|
10:45 am - 12:25 pm
|
|
SESSION TWO
|
|
Chairs: S Webb (Barcelona, Spain),
|
|
A Grossman (London, UK)
|
| |
|
Cushing's disease
|
|
POMC-gene regulation
|
|
Y de Keyzer (Paris, France)
|
|
Diagnosis
|
|
LK Nieman (Bethesda, MD, USA)
|
|
Characterization of ACTH in ectopic Cushing's syndrome
|
|
A White (Manchester, UK)
|
|
Management of recurrent Cushing's disease
|
|
R Fahlbusch (Erlangen, Germany)
|
| |
|
12:25 pm - 1:55 pm
|
|
Lunch seminars
|
| |
|
1:55 pm - 3:35 pm
|
|
SESSION THREE
|
|
Chairs: P Kelly (Paris, France),
|
|
M Bronstein (Sao Paulo, Brazil)
|
| |
|
Prolactinomas
|
|
Role of D2 receptors in pathogenesis of prolactinomas
|
|
M Low (Portland, OR, USA)
|
|
PRL receptor physiology
|
|
V Goffin (Paris, France)
|
|
Gonadal dysfunction/treatment in menopause
|
|
K Miller (Boston, MA, USA)
|
|
Treatment
|
|
D L Kleinberg (New York, NY, USA)
|
| |
|
3:35 pm - 4:05 pm
|
|
Coffee break
|
| |
|
4:05 pm - 5.45 pm
|
|
SESSION FOUR
|
|
Chairs: K Ho (Sydney, Australia),
|
|
P Belchetz (Leeds, UK)
|
| |
|
Acromegaly
|
|
Pathogenesis
|
|
L Persani (Milan, Italy)
|
|
Diagnostic pitfalls
|
|
P Freda (New York, NY, USA)
|
|
Medical management
|
|
JAH Wass (Oxford, UK)
|
|
Role of somatostatin receptor sub-types
|
|
LJ Hofland (Rotterdam, The Netherlands)
|
| |
|
7:30 pm - 9:30 pm
|
|
Starlight Roof Cocktail Reception
|